124 results on '"Jagsi, Reshma"'
Search Results
2. A phase III randomized trial of radiotherapy optimization for low-risk HER2-positive breast cancer (HERO): NRG-BR008.
3. Omission of Radiotherapy After Breast-Conserving Surgery for Women With Breast Cancer With Low Clinical and Genomic Risk: 5-Year Outcomes of IDEA
4. ASCO Ethical Guidance for the Practical Management of Oncology Drug Shortages
5. Omission of Radiotherapy After Breast-Conserving Surgery for Women With Breast Cancer With Low Clinical and Genomic Risk: 5-Year Outcomes of IDEA.
6. ASCO Ethical Guidance for the Practical Management of Oncology Drug Shortages.
7. Reply to G.B. Mann et al and S. Sorscher.
8. ASCO Ethical Guidance for the US Oncology Community Where Reproductive Health Care Is Limited by Law
9. Challenges faced by female oncologists in sub-Saharan Africa.
10. Trainee and program director perspectives of parental leave and parenthood in oncologic specialties.
11. NRG-BR007: A phase III trial evaluating de-escalation of breast radiation (DEBRA) following breast-conserving surgery (BCS) of stage 1, hormone receptor+, HER2-, RS ≤18 breast cancer.
12. Radiation Therapy in Older Adults With Cancer: A Critical Modality in Geriatric Oncology
13. Influence of decision support persons on breast cancer treatment decisions among Latinas.
14. Incidence, Nature, and Consequences of Oncologists' Experiences With Sexual Harassment
15. Picture a Professional: Rethinking Expectations of Medical Professionalism Through the Lens of Diversity, Equity, and Inclusion
16. ‘I’m being forced to make decisions I have never had to make before’: Oncologists and the conundrums created by COVID-19.
17. OCEAN (wOmen’s Career choicEs About oNcology) Study: Motivations to pursue or not pursue academic oncology.
18. Statewide rates of adjuvant checkpoint inhibitor use after definitive chemoradiation for stage III non-small cell lung cancer.
19. Sexual harassment of oncologists.
20. Factors associated with endowed chair allocation in medical oncology divisions and departments in the United States.
21. Shared decision-making attitudes and practices in multidisciplinary cancer care teams.
22. Initial pilot testing of a smartphone app for detection of chemotherapy-induced peripheral neuropathy.
23. Financial and employment toxicity related to breast reconstruction following mastectomy in a diverse population-based cohort.
24. Integration of Breast Reconstruction and Postmastectomy Radiotherapy
25. Ethics and Resource Scarcity: ASCO Recommendations for the Oncology Community During the COVID-19 Pandemic
26. A comprehensive analysis of the demographics and citation-based productivity of radiation oncologists practicing at comprehensive cancer centers.
27. Effect of Public Deliberation on Patient Attitudes Regarding Consent and Data Use in a Learning Health Care System for Oncology
28. Stroke Rates and Risk Factors in Patients Treated With Radiation Therapy for Early-Stage Breast Cancer
29. Rationing and Decision Making
30. Real-Time Rationing of Scarce Resources: The Northeast Proton Therapy Center Experience
31. ENRICH: Validating a multidimensional patient-reported financial toxicity measure.
32. Rising and Falling Trends in the Use of Chemotherapy and Targeted Therapy Near the End of Life in Older Patients With Cancer
33. Cctg MA.39 tailor RT: A randomized trial of regional radiotherapy in biomarker low-risk node-positive breast cancer (NCT03488693).
34. Modeling accrual of older adults to cancer clinical trials: (Alliance A151736).
35. Comparison of Population-Based Observational Studies With Randomized Trials in Oncology
36. The association of age with acute toxicities in NRG oncology combined modality lower GI cancer trials.
37. Improving informed breast cancer systemic treatment decision-making.
38. Toward Improving Patients' Experiences of Acute Toxicity From Breast Radiotherapy: Insights From the Analysis of Patient-Reported Outcomes in a Large Multicenter Cohort.
39. Readability of informed consent forms for cancer patients undergoing radiation therapy: A nationwide survey.
40. Financial toxicity of cancer care: Defining pathways of decline vs resilience.
41. Unmet need for clinician engagement about financial toxicity after diagnosis of breast cancer.
42. Gaps in Receipt of Clinically Indicated Genetic Counseling After Diagnosis of Breast Cancer
43. Improving Breast Cancer Surgical Treatment Decision Making: The iCanDecide Randomized Clinical Trial
44. Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology–Cancer Care Ontario Focused Guideline Update
45. Patient Preferences for Primary Care Provider Roles in Breast Cancer Survivorship Care
46. Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer
47. Perspectives of Patients With Cancer on the Ethics of Rapid-Learning Health Systems
48. What drives overtreatment? Surgeon and radiation oncologist views on omission of adjuvant radiotherapy for elderly women with early stage breast cancer.
49. Recent time trends in chemotherapy use and oncologists' chemotherapy recommendations for early-stage, hormone receptor-positive breast cancer.
50. Treatment decisions and employment of breast cancer patients: Results of a population-based survey.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.